Therapeutic cyclopentane derivatives

Details Therapeutic cyclopentane derivatives Therapeutic cyclopentane derivatives

2007-05-11

2009-06-16

Saeed, Kamal A (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S570000, C558S426000

Reexamination Certificate

active

07547727

ABSTRACT:
Disclosed herein is a compound having a structureor a pharmaceutically acceptable salt, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.

REFERENCES:
patent: 5902726 (1999-05-01), Kliewer et al.
patent: 2006/0205800 (2006-09-01), Donde et al.
patent: 1211241 (2000-06-01), None
patent: 1 506 485 (1978-04-01), None
patent: WO95/19964 (1995-07-01), None
Mandred E. Wolff, Burger's Medicinal Chemistry and Drug Discovery, 1994, Wiley-Interscience, Fifth Edition, vol. I: Principles and Practice, 975-977.
Dragoli, et al., “Parallel Sysnthesis of Prostaglandin E1 Analogues,” J. Comb. Chem, 19999, I, pp. 534-539.
Grudzinskas, Charles V., et al., “Prostaglandins and Congeners IV. The Sysnthesis of Certain 11-Substituted Derivatives of 11-Deoxyprostaglandin E2 and F2 From 15-0-Acetylprostaglandin A2 Methyl Ester,” Tetrahedron Letters,1973, No. 2, pp. 141-144.
Baxter, Anthony D., et al., “Synthesis and Use of 7-Substituted Norbornadienes + for the Preparation of Prostaglandins and Prostanoids,” J. Chem. Soc. Perkin Trans., I 1986, pp. 889-900.

Affiliated with

Also associated with

Rating

Therapeutic cyclopentane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic cyclopentane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic cyclopentane derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4148707